TGF-β Antagonists: Why Suppress a Tumor Suppressor?

Journal of Clinical Investigation - United States
doi 10.1172/jci0215970
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

TGF-β Switches From Tumor Suppressor to Prometastatic Factor in a Model of Breast Cancer Progression

Journal of Clinical Investigation
Medicine
2003English

NM23-H1 Tumor Suppressor Physically Interacts With Serine-Threonine Kinase Receptor-Associated Protein, a Transforming Growth Factor-Β (TGF-β) Receptor-Interacting Protein, and Negatively Regulates TGF-β Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Tumor Suppressor NDRG2 Tips the Balance of Oncogenic TGF-β via EMT Inhibition in Colorectal Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2014English

Erbin and the NF2 Tumor Suppressor Merlin Cooperatively Regulate Cell-Type-Specific Activation of PAK2 by TGF-β

Developmental Cell
BiochemistryDevelopmental BiologyGeneticsCell BiologyMolecular Biology
2009English

Impairment of NKG2D-Mediated Tumor Immunity by TGF-β

Frontiers in Immunology
AllergyImmunology
2019English

microRNA-1827 Represses MDM2 to Positively Regulate Tumor Suppressor P53 and Suppress Tumorigenesis

Oncotarget
Oncology
2016English

TGF-β Family Signaling in Tumor Suppression and Cancer Progression

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2017English

Critical Interactions Between TGF-β Signaling/Elf, and E-Cadherin/Β-Catenin Mediated Tumor Suppression

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

TGF-β Signaling

WormBook
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy